Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Arguing for postmenopausal estrogen with respect to heart disease risk

    • 1 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Arguing for postmenopausal estrogen with respect to heart disease risk. Inpharma Wkly. 685, 5–6 (1989). https://doi.org/10.1007/BF03286281

    Download citation

    Keywords

    • Estrogen
    • Endometrial Cancer
    • Endometrial Carcinoma
    • Postmenopausal Bone Loss
    • Unopposed Estrogen